Group I metabotropic glutamate receptors: Involvement in drug-seeking and drug-induced plasticity

Current Molecular Pharmacology

Volumn 2, Issue 1, 2009, Pages 83-94

  Bird, M K ^a   Lawrence, A J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Addiction; Cocaine; Dependence; Ethanol; Metabotropic glutamate receptor; Motivation; Reward

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; ALCOHOL; CANNABINOID; COCAINE; DIZOCILPINE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; MORPHINE; OPIATE; ALCOHOL DERIVATIVE; CALCIUM; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; NICOTINE; OPIATE PEPTIDE;

ADDICTION; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; DRUG ABUSE; DRUG ACTIVITY; DRUG MEGADOSE; HUMAN; MORPHINE ADDICTION; NERVE CELL PLASTICITY; NERVE TRACT; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ALCOHOLS; ANIMALS; CALCIUM; COCAINE; HUMANS; MICE; NEURONAL PLASTICITY; NICOTINE; OPIOID PEPTIDES; RECEPTORS, METABOTROPIC GLUTAMATE; SUBSTANCE-RELATED DISORDERS;

EID: 70449654395     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467210902010083     Document Type: Article

References (202)

1. Aldworth, J.; Ault, K.; Bishop, E. Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293: Rockville, MD 2007.
2. Pouletty, P. Drug addictions: towards socially accepted and medically treatable diseases. Nat. Rev. Drug Discov. 2002, 1, 731-6.
3. Central Intelligence Agency. The World Factbook. Office of Public Affairs: Washington, DC 2008.
4. Hyman, S. E.; Malenka, R. C. Addiction and the brain: The neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2001, 2, 695-703.
5. Koob, G. F.; LeMoal, M. Drug abuse: Hedonic homeostatic dysregulation. Science 1997, 278, 52-58.
6. Koob, G. F.; Le Moal, M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24, 97-129.
7. Koob, G. F.; Le Moal, M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 2005, 8, 1442-1444.
8. Solomon, R. L. The opponent-process theory of acquired motivation - the costs of pleasure and the benefits of pain. Am. Psychol. 1980, 35, 691-712.
9. Solomon, R. L.; Corbit, J. D. Opponent-process theory of motivation.1. temporal dynamics of affect. Psychol. Rev. 1974, 81, 119-145.
10. Grimm, J. W.; Hope, B. T.; Wise, R. A.; Shaham, Y. Neuroadaptation: Incubation of cocaine craving after withdrawal. Nature 2001, 412, 141-142.
11. Robinson, T. E.; Berridge, K. C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 1993, 18, 247-291.
12. Robinson, T. E.; Berridge, K. C. Addiction. Annu. Rev. Psychol. 2003, 54, 25-53.
13. Berridge, K. C.; Robinson, T. E. What is the role of dopamine in reward: hedonic impact, reward learning or incentive salience? Brain Res. Rev. 1998, 28, 309-369.
14. Robinson, T. E.; Berridge, K. C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000, 95, S91-S117.
15. Robinson, T. E.; Berridge, K. C. Incentive-sensitization and addiction. Addiction 2001, 96, 103-114.
16. Nestler, E. J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2001, 2, 119-128.
17. Di Chiara, G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J. Psychopharmacol. 1998, 12, 54-67.
18. Di Chiara, G. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 1999, 375, 13-30.
19. Robbins, T. W.; Everitt, J. Limbic-striatal memory systems and drug addiction. Neurobiol. Learn. Mem. 2002, 78, 625-636.
20. Ramon y Cajal, S. La fine structures des centres nerveux. Proc. R. Soc. Lond. 1894, 55, 444-468.
21. Citri, A.; Malenka, R. C. Synaptic plasticity: Multiple forms, functions, and mechanisms. Neuropsychopharmacology 2008, 33, 18-41.
22. Malenka, R. C.; Bear, M. F. LTP and LTD: An embarrassment of riches. Neuron 2004, 44, 5-21.
23. Kauer, J. A. Learning mechanisms in addiction: Synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu. Rev. Physiol. 2004, 66, 447-475.
24. Horne, M. K.; Lee, J.; Chen, F.; Lanning, K.; Tomas, D.; Lawrence, A. J. Long-term administration of cocaine or serotonin reuptake inhibitors results in anatomical and neurochemical changes in noradrenergic, dopaminergic, and serotonin pathways. J. Neurochem. 2008, 106, 1731-1744.
25. Ungless, M. A.; Whistler, J. L.; Malenka, R. C.; Bonci, A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001, 411, 583-587.
26. Kim, H. S.; Jang, C. G.; Park, W. K. Inhibition by MK-801 of morphine- induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 1996, 55, 11-17.
27. Schenk, S.; Valadez, A.; Worley, C. M.; McNamara, C. Blockade of the acquisition of cocaine self-administration by the NMDA antagonist MK-801 (Dizocilpine). Behav. Pharmacol. 1993, 4, 652-659.
28. Kim, H. S.; Park, W. K.; Jang, C. G.; Oh, S. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 1996, 40, 201-207.
29. Kalivas, P. W.; Alesdatter, J. E. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 1993, 267, 486-495.
30. Ito, K.; Abekawa, T.; Koyama, T. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Psychopharmacology 2006, 187, 293-302.
31. Robinson, T. E.; Becker, J. B. Enduring changes in brain and behavior produced by chronic amphetamine administration - a review and evaluation of animal-models of amphetamine psychosis. Brain Res. Rev. 1986, 11, 157-198.
32. Kalivas, P. W.; Stewart, J. Dopamine transmission in the initiation and expression of drug-induced and stress-induced sensitization of motoractivity. Brain Res. Rev. 1991, 16, 223-244.
33. Cador, M.; Bjijou, Y.; Stinus, L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 1995, 65, 385-395.
34. Vezina, P.; Kalivas, P. W.; Stewart, J. Sensitization occurs to the locomotor effects of morphine and the specific mu-opioid receptor agonist, dago, administered repeatedly to the ventral tegmental area but not to the aucleusaccumbens. Brain Res. 1987, 417, 51-58.
35. Kauer, J. A.; Malenka, R. C. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 2007, 8, 844-858.
36. Smith, A. D.; Bolam, J. P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 1990, 13, 259-265.
37. Robinson, T. E.; Gorny, G.; Mitton, E.; Kolb, B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001, 39, 257-266.
38. Robinson, T. E.; Kolb, B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 1999, 11, 1598-1604.
39. Lee, K.-W.; Kim, Y.; Kim, A. M.; Helmin, K.; Nairn, A. C.; Greengard, P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor- containing medium spiny neurons in nucleus accumbens. Proc. Natl. Acad. Sci. USA 2006, 103, 3399-3404.
40. Norrholm, S. D.; Bibb, J. A.; Nestler, E. J.; Ouimet, C. C.; Taylor, J. R.; Greengard, P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003, 119, 619-619.
41. Robinson, T. E.; Kolb, B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 1999, 33, 160-162.
42. Zhou, F. C.; Anthony, B.; Dunn, K. W.; Lindquist, W. B.; Xu, Z. C.; Deng, P. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res. 2007, 1134, 148-161.
43. Kalivas, P. W.; Duffy, P. D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 1995, 15, 5379-5388.
44. Kalivas, P. W.; Duffy, P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem. 1998, 70, 1497-1502.
45. Hotsenpiller, G.; Giorgetti, M.; Wolf, M. E. Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure. Eur. J. Neurosci. 2001, 14, 1843-1855.
46. Hotsenpiller, G.; Wolf, M. E. Extracellular glutamate levels in prefrontal cortex during the expression of associative responses to cocaine related stimuli. Neuropharmacology 2002, 43, 1218-1229.
47. McFarland, K.; Lapish, C. C.; Kalivas, P. W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2003, 23, 3531-3537.
48. Harris, G. C.; Aston-Jones, G. Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology 2003, 28, 73-76.
49. Kalivas, P. W.; McFarland, K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 2003, 168, 44-56.
50. Bamford, N. S.; Zhang, H.; Joyce, J. A.; Scarlis, C. A.; Hanan, W.; Wu, N.-P.; André, V. M.; Cohen, R.; Cepeda, C.; Levine, M. S.; Harleton, E.; Sulzer, D. Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron 2008, 58, 89-103.
51. Kew, J. N. C.; Kemp, J. A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 2005, 179, 4-29.
52. Sladeczek, F.; Pin, J. P.; Recasens, M.; Bockaert, J.; Weiss, S. Glutamate stimulates inositol phosphate formation in striatal neurons. Nature 1985, 317, 717-719.
53. Sugiyama, H.; Ito, I.; Hirono, C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature 1987, 325, 531-533.
54. Houamed, K. M.; Kuijper, J. L.; Gilbert, T. L.; Haldeman, B. A.; Ohara, P. J.; Mulvihill, E. R.; Almers, W.; Hagen, F. S. Cloning, expression, and gene structure of a g-protein-coupled glutamate receptor from rat-brain. Science 1991, 252, 1318-1321.
55. Abe, T.; Sugihara, H.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J. Biol. Chem. 1992, 267, 13361-13368.
56. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. A family of metabotropic glutamate receptors. Neuron 1992, 8, 169-179.
57. Nakajima, Y.; Iwakabe, H.; Akazawa, C.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4- phosphonobutyrate. J. Biol. Chem. 1993, 268, 11868-11873.
58. Okamoto, N.; Hori, S.; Akazawa, C.; Hayashi, Y.; Shigemoto, R.; Mizuno, N.; Honda, Y.; Nakanishi, S. Molecular characterization of a new metabotropic glutamate-receptor mGluR7 coupled to inhibitory cyclic-amp signal-transduction. Invest. Ophth. Vis. Sci. 1994, 35, 1584-1584.
59. Duvoisin, R. M.; Zhang, C. X.; Ramonell, K. A novel metabotropic glutamate-receptor expressed in the retina and olfactory-bulb. J. Neurosci. 1995, 15, 3075-3083.
60. Masu, M.; Tanabe, Y.; Tsuchida, K.; Shigemoto, R.; Nakanishi, S. Sequence and expression of a metabotropic glutamate receptor. Nature 1991, 349, 760-765.
61. Conn, P. J.; Pin, J. P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 1997, 37, 205-237.
62. Gama, L.; Wilt, S. G.; Breitwieser, G. E. Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons. J. Biol. Chem. 2001, 276, 39053-39059.
63. Ferre, S.; Karcz-Kubicha, M.; Hope, B. T.; Popoli, P.; Burgueno, J.; Gutierrez, M. A.; Casado, V.; Fuxe, K.; Goldberg, S. R.; Lluis, C.; Franco, R.; Ciruela, F. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function. Proc. Natl. Acad. Sci. USA 2002, 99, 11940-11945.
64. Ciruela, F.; Escriche, M.; Burgueno, J.; Angulo, E.; Casado, V.; Soloviev, M. M.; Canela, E. I.; Mallol, J.; Chan, W. Y.; Lluis, C.; McIlhinney, R. A. J.; Franco, R. Metabotropic glutamate 1 alpha and adenosine A1 receptors assemble into functionally interacting complexes. J. Biol. Chem. 2001, 276, 18345-18351.
65. Peavy, R. D.; Chang, M. S. S.; Sanders-Bush, E.; Conn, P. J. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J. Neurosci. 2001, 21, 9619-9628.
66. Hoffpauir, B. K.; Gleason, E. L. Activation of mGluR5 modulates GABA(A) receptor function in retinal amacrine cells. J. Neurophysiol. 2002, 88, 1766-1776.
67. Fourgeaud, L.; Mato, S.; Bouchet, D.; Hemar, A.; Worley, P. F.; Manzoni, O. J. A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J. Neurosci. 2004, 24, 6939-6945.
68. Robbe, D.; Alonso, G.; Manzoni, O. J. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann. N. Y. Acad. Sci. 2003, 1003, 212-225.
69. Grueter, B. A.; Gosnell, H. B.; Olsen, C. M.; Schramm-Sapyta, N. L.; Nekrasova, T.; Landreth, G. E.; Winder, D. G. Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J. Neurosci. 2006, 26, 3210-3219.
70. Kornau, H.-C.; Schenker, L. T.; Kennedy, M. B.; Seeburg, P. H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 1995, 269, 1737-1740.
71. Tu, J. C.; Xiao, B.; Naisbitt, S.; Yuan, J. P.; Petralia, R. S.; Brakeman, P.; Doan, A.; Aakalu, V. K.; Lanahan, A. A.; Sheng, M.; Worley, P. F. Coupling of mGluR/Homer and PSD-95 complexes by the shank family of postsynaptic density proteins. Neuron 1999, 23, 583-592.
72. Heuss, C.; Scanziani, M.; Gahwiler, B. H.; Gerber, U. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat. Neurosci. 1999, 2, 1070-1077.
73. Watabe, A. M.; Carlisle, H. J.; O'Dell, T. J. Postsynaptic induction and presynaptic expression of group 1 mGluR-dependent LTD in the hippocampal CA1 region. J. Neurophysiol. 2002, 87, 1395-1403.
74. Lujan, R.; Nusser, Z.; Roberts, J. D. B.; Shigemoto, R.; Somogyi, P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 1996, 8, 1488-1500.
75. Tallaksen-Greene, S. J.; Kaatz, K. W.; Romano, C.; Albin, R. L. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 1998, 780, 210-217.
76. Attucci, S.; Carla, V.; Mannaioni, G.; Moroni, F. Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges. Br. J. Pharmacol. 2001, 132, 799-806.
77. Awad, H.; Hubert, G. W.; Smith, Y.; Levey, A. I.; Conn, P. J. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J. Neurosci. 2000, 20, 7871-7879.
78. Anwyl, R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Rev. 1999, 29, 83-120.
79. Swanson, C. J.; Baker, D. A.; Carson, D.; Worley, P. F.; Kalivas, P. W. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: A potential role for Homer. J. Neurosci. 2001, 21, 9043-9052.
80. Musante, V.; Neri, E.; Feligioni, M.; Puliti, A.; Pedrazzi, M.; Conti, V.; Usai, C.; Diaspro, A.; Ravazzolo, R.; Henley, J. M.; Battaglia, G.; Pittaluga, A. Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings. Neuropharmacology 2008, 55, 474-482.
81. Shigemoto, R.; Nomura, S.; Ohishi, H.; Sugihara, H.; Nakanishi, S.; Mizuno, N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 1993, 163, 53-57.
82. Romano, C.; Sesma, M. A.; McDonald, C. T.; O'malley, K.; van den Pol, A. N.; Olney, J. W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 1995, 355, 455-469.
83. Lavreysen, H.; Pereira, S. N.; Leysen, J. E.; Langlois, X.; Lesage, A. S. J. Metabotropic glutamate 1 receptor distribution and occupancy in the rat brain: a quantitative autoradiographic study using H-3 R214127. Neuropharmacology 2004, 46, 609-619.
84. Bruton, R. F.; Ge, J.; Barnes, N. M. Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo. Eur. J. Pharmacol. 1999, 369, 175-181.
85. Renoldi, G.; Calcagno, E.; Borsini, F.; Invernizzi, R. W. Stimulation of group I mGlu receptors in the ventrotegmental area enhances extracellular dopamine in the rat medial prefrontal cortex. J. Neurochem. 2007, 100, 1658-1666.
86. Page, G.; Peeters, M.; Najimi, M.; Maloteaux, J. M.; Hermans, E. Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. J. Neurochem. 2001, 76, 1282-1290.
87. Chiamulera, C.; Epping-Jordan, M. P.; Zocchi, A.; Marcon, C.; Cottiny, C.; Tacconi, S.; Corsi, M.; Orzi, F.; Conquet, F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 2001, 4, 873-874.
88. Chen, B. T.; Bowers, M. S.; Martin, M.; Hopf, F. W.; Guillory, A. M.; Carelli, R. M.; Chou, J. K.; Bonci, A. Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 2008, 59, 288-297.
89. Ghasemzadeh, M. B.; Nelson, L. C.; Lu, X.-Y.; Kalivas, P. W. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J. Neurochem. 1999, 72, 157-165.
90. Freeman, W. M.; Brebner, K.; Lynch, W. J.; Robertson, D. J.; Roberts, D. C. S.; Vrana, K. E. Cocaine-responsive gene expression changes in rat hippocampus. Neuroscience 2001, 108, 371-380.
91. Backstrom, P.; Hyytia, P. Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacol. 2006, 31, 778-786.
92. Iso, Y.; Grajkowska, E.; Wroblewski, J. T.; Davis, J.; Goeders, N. E.; Johnson, K. M.; Sanker, S.; Roth, B. L.; Tueckmantel, W.; Kozikowski, A. P. Synthesis and structure-activity relationships of 3- (2-methyl-1,3-thiazol-4- yl)ethynyl pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; Search for cocaine medications. J. Med. Chem. 2006, 49, 1080-1100.
93. Lee, B.; Platt, D. M.; Rowlett, J. K.; Adewale, A. S.; Spealman, R. D. Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J. Pharmacol. Exp. Ther. 2005, 312, 1232-1240.
94. Ghasemzadeh, M. B.; Permenter, L. K.; Lake, R.; Worley, P. F.; Kalivas, P. W. Homer1 proteins and AMPA receptors modulate cocaine-induced behavioural plasticity. Eur. J. Neurosci. 2003, 18, 1645-1651.
95. Szumlinski, K. K.; Dehoff, M. H.; Kang, S. H.; Frys, K. A.; Lominac, K. D.; Klugmann, M.; Rohrer, J.; Griffin, W.; Toda, S.; Champtiaux, N. P.; Berry, T.; Tu, J. C.; Shealy, S. E.; During, M. J.; Middaugh, L. D.; Worley, P. F.; Kalivas, P. W. Homer proteins regulate sensitivity to cocaine. Neuron 2004, 43, 401-413.
96. Ary, A. W.; Szumlinski, K. K. Regional differences in the effects of withdrawal from repeated cocaine upon Homer and glutamate receptor expression: A two-species comparison. Brain Res. 2007, 1184, 295-305.
97. Herzig, V.; Schmidt, W. J. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Neuropharmacology 2004, 47, 973-984.
98. McGeehan, A. J.; Olive, M. F. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 2003, 47, 240-242.
99. Dravolina, O. A.; Danysz, W.; Bespalov, A. Y. Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats. Psychopharmacology 2006, 187, 397-404.
100. Kenny, P. J.; Paterson, N. E.; Boutrel, B.; Semenova, S.; Harrison, A.; Gasparini, F.; Koob, G. F.; Skoubis, P. D.; Markou, A. Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann. N. Y. Acad. Sci. 2003, 1003, 415-418.
101. Paterson, N. E.; Markou, A. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 2005, 179, 255-261.
102. Kenny, P. J.; Boutrel, B.; Gasparini, F.; Koob, G. F.; Markou, A. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self- administration by decreasing brain reward function in rats. Psychopharmacology 2005, 179, 247-54.
103. Parelkar, N. K.; Wang, J. Q. mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine. Mol. Brain Res. 2004, 122, 151-157.
104. Choe, E. S.; Chung, K. T.; Mao, L. M.; Wang, J. Q. Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacol. 2002, 27, 565-575.
105. Choe, E. S.; Wang, J. Q. Regulation of transcription factor phosphorylation by metabotropic glutamate receptor-associated signaling pathways in rat striatal neurons. Neuroscience 2002, 114, 557-565.
106. Pietraszek, M.; Rogoz, Z.; Wolfarth, S.; Ossowska, K. Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine. J. Physiol. Pharmacol., 2004, 55, 587-593.
107. Yap, J. J.; Covington, H. E.; Gale, M. C.; Datta, R.; Miczek, K. A. Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors. Psychopharmacology 2005, 179, 230-239.
108. Pisani, A.; Gubellini, P.; Bonsi, P.; Conquet, F.; Picconi, B.; Centonze, D.; Bernardi, G.; Calabresi, P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience 2001, 106, 579-587.
109. Mao, L. M.; Wang, J. Q. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration. Synapse 2001, 41, 230-240.
110. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237, 1219-1223.
111. Yu, M. F.; Fu, W. M.; Yin, H. S. Effect of amphetamine on the expression of the metabotropic glutamate receptor 5 mRNA in developing rat brain. J. Mol. Neurosci. 2000, 15, 177-188.
112. Yu, M. F.; Lin, T. Y.; Ho, W. H.; Yin, H. S. Amphetamine induces differential changes in the gene expression of metabotropic glutamate receptor 5 in cultured cortical and hippocampal neurons. J. Mol. Neurosci., 2001, 17, 13-24.
113. Yu, M. F.; Lin, W. W.; Li, L. T.; Yin, H. S. Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons. Synapse 2003, 50, 334-344.
114. Schwendt, M.; McGinty, J. F. Regulator of g-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine Behavioral Sensitization. J. Pharmacol. Exp. Ther. 2007, 323, 650-657.
115. Mao, L.; Conquet, F.; Wang, J. Q. Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice. Neuroscience, 2001, 106, 303-312.
116. Lominac, K. D.; Kapasova, Z.; Hannun, R. A.; Patterson, C.; Middaugh, L. D.; Szumlinski, K. K. Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: Potential insight into their antiaddictive properties. Drug Alcohol Depend. 2006, 85, 142-156.
117. Schumann, G.; Johann, M.; Frank, J.; Preuss, U.; Dahmen, N.; Laucht, M.; Rietschel, M.; Rujescu, D.; Lourdusamy, A.; Clarke, T.-K.; Krause, K.; Dyer, A.; Depner, M.; Wellek, S.; Treutlein, J.; Szegedi, A.; Giegling, I.; Cichon, S.; Blomeyer, D.; Heinz, A.; Heath, S.; Lathrop, M.; Wodarz, N.; Soyka, M.; Spanagel, R.; Mann, K. Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch. Gen. Psychiatry 2008, 65, 826-838.
118. Woodward, J. J. Ethanol and NMDA receptor signaling. Crit. Rev. Neurobiol. 2000, 14, 69-89.
119. Szumlinski, K. K.; Lominac, K. D.; Oleson, E. B.; Walker, J. K.; Mason, A.; Dehoff, M. H.; Klugman, M.; Cagle, S.; Welt, K.; During, M.; Worley, P. F.; Middaugh, L. D.; Kalivas, P. W. Homer2 is necessary for EtOH-induced neuroplasticity. J. Neurosci. 2005, 25, 7054-7061.
120. Szumlinski, K. K.; Ary, A. W.; Lominac, K. D.; Klugmann, M.; Kippin, T. E. Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacol. 2008, 33, 1365-1378.
121. Simonyi, A.; Zhang, J. P.; Sun, A. Y.; Sun, G. Y. Chronic ethanol on mRNA levels of IP(3)R1, IP3 3-kinase and mGluR1 in mouse Purkinje neurons. Neuroreport 1996, 7, 2115-2118.
122. Simonyi, A.; Christian, M. R.; Sun, A. Y.; Sun, G. Y. Chronic ethanol-induced subtype- and subregion-specific decrease in the mRNA expression of metabotropic glutamate receptors in rat hippocampus. Alcohol. Clin. Exp. Res. 2004, 28, 1419-1423.
123. Kawabata, S.; Kohara, A.; Tsutsumi, R.; Itahana, H.; Hayashibe, S.; Yamaguchi, T.; Okada, M. Diversity of calcium signaling by metabotropic glutamate receptors. J. Biol. Chem. 1998, 273, 17381-17385.
124. Kim, C. H.; Braud, S.; Isaac, J. T. R.; Roche, K. W. Protein kinase C phosphorylation of the metabotropic glutamate receptor mGluR5 on serine 839 regulates Ca2+ oscillations. J. Biol. Chem. 2005, 280, 25409-25415.
125. Netzeband, J. G.; Gruol, D. L. Modulatory effects of acute ethanol on metabotropic glutamate responses in cultured purkinje neurons. Brain Res. 1995, 688, 105-113.
126. Minami, K.; Gereau, R. W.; Minami, M.; Heinemann, S. F.; Harris, R. A. Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes. Mol. Pharmacol. 1998, 53, 148-156.
127. Othman, T.; Sinclair, C. J. D.; Haughey, N.; Geiger, J. D.; Parkinson, F. E. Ethanol alters glutamate but not adenosine uptake in rat astrocytes: Evidence for protein kinase C involvement. Neurochem. Res. 2002, 27, 289-296.
128. Choi, D.-S.; Wang, D.; Dadgar, J.; Chang, W. S.; Messing, R. O. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J. Neurosci. 2002, 22, 9905-9911.
129. Hodge, C. W.; Mehmert, K. K.; Kelley, S. P.; McMahon, T.; Haywood, A.; Olive, M. F.; Wang, D.; Sanchez-Perez, A. M.; Messing, R. O. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat. Neurosci. 1999, 2, 997-1002.
130. Bird, M. K.; Kirchhoff, J.; Djouma, E.; Lawrence, A. J. Metabotropic glutamate 5 receptors regulate sensitivity to ethanol in mice. Int. J. Neuropsychopharmacol. 2008, 11, 765-774.
131. Sharko, A. C.; Hodge, C. W. Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice. Alcohol. Clin. Exp. Res. 2008, 32, 67-76.
132. Olive, M. F.; McGeehan, A. J.; Kinder, J. R.; McMahon, T.; Hodge, C. W.; Janak, P. H.; Messing, R. O. The mGluR5 antagonist 6-methyl-2- (phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol. Pharmacol. 2005, 67, 349-355.
133. Miyoshi, K.; Narita, M.; Suzuki, T. Involvement of mGluR5 in the ethanol-induced neuropathic pain-like state in the rat. Neurosci. Lett. 2006, 410, 105-109.
134. Miyoshi, K.; Narita, M.; Takatsu, M.; Suzuki, T. mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption. Eur. J. Pharmacol. 2007, 562, 208-211.
135. Kotlinska, J.; Bochenski, M.; Danysz, W. N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanolinduced sensitization in mice. Behav. Pharmacol. 2006, 17, 1-8.
136. Besheer, J.; Faccidomo, S.; Grondin, J. J. M.; Hodge, C. W. Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 2008, 32, 209-221.
137. Harris, B. R.; Gibson, D. A.; Prendergast, M. A.; Blanchard, J. A.; Holley, R. C.; Hart, S. R.; Scotland, R. L.; Foster, T. C.; Pedigo, N. W.; Littleton, J. M. The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors. Alcohol. Clin. Exp. Res. 2003, 27, 1724-1735.
138. Harris, B. R.; Prendergast, M. A.; Gibson, D. A.; Rogers, D. T.; Blanchard, J. A.; Holley, R. C.; Fu, M. C.; Hart, S. R.; Pedigo, N. W.; Littleton, J. M. Acamprosate inhibits the binding and neurotoxic effects of Trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol. Clin. Exp. Res. 2002, 26, 1779-1793.
139. Rossetti, Z. L.; Carboni, S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 1995, 283, 177-183.
140. De Witte, P.; Littleton, J.; Parot, P.; Koob, G. Neuroprotective and abstinence-promoting effects of acamprosate - Elucidating the mechanism of action. CNS Drugs 2005, 19, 517-537.
141. Cowen, M. S.; Djouma, E.; Lawrence, A. J. The metabotropic glutamate 5 receptor antagonist 3- [(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. J. Pharmacol. Exp. Ther. 2005, 315, 1-11.
142. McMillen, B. A.; Crawford, M. S.; Kulers, C. M.; Williams, H. L. Effects of a metabotropic, mGlu5, glutamate receptor antagonist on ethanol consumption by genetic drinking rats. Alcohol Alcoholism 2005, 40, 494-497.
143. Schroeder, J. P.; Overstreet, D. H.; Hodge, C. W. The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology 2005, 179, 262-270.
144. Hodge, C. W.; Miles, M. F.; Sharko, A. C.; Stevenson, R. A.; Hillmann, J. R.; Lepoutre, V.; Besheer, J.; Schroeder, J. P. The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacology 2006, 183, 429-438.
145. Cowen, M. S.; Krstew, E.; Lawrence, A. J. Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism. Psychopharmacology 2007, 190, 21-29.
146. Backstrom, P.; Bachteler, D.; Koch, S.; Hyytia, P.; Spanagel, R. mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacol. 2004, 29, 921-928.
147. Besheer, J.; Faccidomo, S.; Grondin, J. J. M.; Hodge, C. W. Effects of mGlu1-receptor blockade on ethanol self-administration in inbred alcohol-preferring rats. Alcohol 2008, 42, 13-20.
148. Ugolini, A.; Corsi, M.; Bordi, F. Potentiation of NMDA and AMPA responses by the specific mGluR(5) agonist CHPG in spinal cord motoneurons. Neuropharmacology 1999, 38, 1569-1576.
149. Harney, S. C.; Rowan, M.; Anwyl, R. Long-term depression of NMDA receptor-mediated synaptic transmission is dependent on activation of metabotropic glutamate receptors and is altered to long-term potentiation by low intracellular calcium buffering. J. Neurosci. 2006, 26, 1128-1132.
150. Jia, Z. P.; Lu, Y. M.; Henderson, J.; Taverna, F.; Romano, C.; Abramow-Newerly, W.; Wojtowicz, J. M.; Roder, J. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn. Mem. 1998, 5, 331-343.
151. Yang, X. O.; Horn, K.; Wand, G. S. Chronic ethanol exposure impairs phosphorylation of CREB and CRE-binding activity in rat striatum. Alcohol. Clin. Exp. Res. 1998, 22, 382-390.
152. Schenk, S.; Valadez, A.; McNamara, C.; House, D. T.; Higley, D.; Bankson, M. G.; Gibbs, S.; Horger, B. A. Development and expression of sensitization to cocaine reinforcing properties - role of NMDA receptors. Psychopharmacology 1993, 111, 332-338.
153. Homayoun, H.; Stefani, M. R.; Adams, B. W.; Tamagan, G. D.; Moghaddam, B. Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacol. 2004, 29, 1259-1269.
154. Pohorecky, L. A. Biphasic Action of Ethanol. Biobehavioral Rev. 1977, 1, 231-240.
155. Hodge, C. W.; Cox, A. A.; Bratt, A. M.; Camarini, R.; Iller, K.; Kelley, S. P.; Mehmert, K. K.; Nannini, M. A.; Olive, M. F. The discriminative stimulus properties of self-administered ethanol are mediated by GABA(A) and NMDA receptors in rats. Psychopharmacology 2001, 154, 13-22.
156. Besheer, J.; Hodge, C. W. Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha 1-containing receptors in the discriminative stimulus effects of ethanol. Neuropsychopharmacol. 2005, 30, 747-757.
157. Pintor, A.; Pezzola, A.; Reggio, R.; Quarta, D.; Popoli, P. The mGlu(5) receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A(2A) receptors. Neuroreport 2000, 11, 3611-3614.
158. Nishi, A.; Liu, F.; Matsuyama, S.; Hamada, M.; Higashi, H.; Nairn, A. C.; Greengard, P. Metabotropic mGlu5 receptors regulate adenosine A(2A) receptor signaling. Proc. Natl. Acad. Sci. USA 2003, 100, 1322-1327.
159. Rodrigues, R. J.; Alfaro, T. M.; Rebola, N.; Oliveira, C. R.; Cunha, R. A. Colocalization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem. 2005, 92, 433-441.
160. Kachroo, A.; Orlando, L. R.; Grandy, D. K.; Chen, J. F.; Young, A. B.; Schwarzschild, M. A. Interactions between metabotropic glutamate 5 and adenosine A(2A) receptors in normal and parkinsonian mice. J. Neurosci. 2005, 25, 10414-10419.
161. Coccurello, R.; Breysse, N.; Amalric, M. Simultaneous blockade of adenosine A(2A) and metabotropic glutamate mGlu(5) receptors increase their efficacy in reversing parkinsonian deficits in rats. Neuropsychopharmacol. 2004, 29, 1451-1461.
162. Arolfo, M. P.; Yao, L.; Gordon, A. S.; Diamond, I.; Janak, P. H. Ethanol operant self-administration in rats is regulated by adenosine A(2) receptors. Alcohol. Clin. Exp. Res. 2004, 28, 1308-1316.
163. Adams, C. L.; Cowen, M. S.; Short, J. L.; Lawrence, A. J. Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats. Int. J. Neuropsychopharmacol. 2008, 11, 229-241.
164. Kane, J. K.; Hwang, Y.; Konu, O.; Loughlin, S. E.; Leslie, F. M.; Li, M. D. Regulation of Homer and group I metabotropic glutamate receptors by nicotine. Eur. J. Neurosci. 2005, 21, 1145-1154.
165. Harrison, A. A.; Gasparini, F.; Markou, A. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology 2002, 160, 56-66.
166. Welsby, P.; Rowan, M.; Anwyl, R. Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus. Eur. J. Neurosci. 2006, 24, 3109-3118.
167. Parodi, M.; Patti, L.; Grilli, M.; Raiteri, M.; Marchi, M. Nicotine has a permissive role on the activation of metabotropic glutamate 5 receptors coexisting with nicotinic receptors on rat hippocampal noradrenergic nerve terminals. Neurochem. Int. 2006, 48, 138-143.
168. Liechti, M. E.; Markou, A. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Eur. J. Pharmacol. 2007, 554, 164-174.
169. Paterson, N. E.; Semenova, S.; Gasparini, F.; Markou, A. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 2003, 167, 257-264.
170. Tessari, M.; Pilla, M.; Andreoli, M.; Hutcheson, D. M.; Heidbreder, C. A. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. Eur. J. Pharmacol. 2004, 499, 121-133.
171. Bespalov, A. Y.; Dravolina, O. A.; Sukhanov, I.; Zakharova, E.; Blokhina, E.; Zvartau, E.; Danysz, W.; van Heeke, G.; Markou, A. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology 2005, 49, 167-178.
172. Dravolina, O. A.; Zakharova, E. S.; Shekunova, E. V.; Zvartau, E. E.; Danysz, W.; Bespalov, A. Y. mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats. Neuropharmacology 2007, 52, 263-269.
173. Frenois, F.; Le Moine, C.; Cador, M. The motivational component of with- drawal in opiate addiction: Role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective. Rev. Neurosci. 2005, 16, 255-276.
174. Rasmussen, K.; Martin, H.; Berger, J. E.; Seager, M. A. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine with- drawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats. Neuropharmacology 2005, 48, 173-180.
175. Kotlinska, J.; Bochenski, M. Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice. Eur. J. Pharmacol. 2007, 558, 113-118.
176. Xu, T.; Jiang, W.; Du, D. P.; Xu, Y. M.; Hu, Q.; Shen, Q. Role of spinal metabotropic glutamate receptor subtype 5 in the development of tolerance to morphine-induced antinociception in rat. Neurosci. Lett. 2007, 420, 155-159.
177. Narita, M.; Suzuki, M.; Niikura, K.; Nakamura, A.; Miyatake, M.; Aoki, T.; Yajima, Y.; Suzuki, T. Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception. J. Neurochem. 2005, 94, 1297-1305.
178. Popik, P.; Wrobel, M. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 2002, 43, 1210-1217.
179. Lea, P. M.; Faden, A. I. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev. 2006, 12, 149-166.
180. Aoki, T.; Narita, M.; Shibasaki, M.; Suzuki, T. Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice. Eur. J. Neurosci. 2004, 20, 1633-1638.
181. Van der Kam, E. L.; De Vry, J.; Tzschentke, T. M. Effect of 2-methyl-6- (phenyl ethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behav. Pharmacol. 2007, 18, 717-724.
182. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a Cannabinoid Receptor and Functional Expression of the Cloned cDNA. Nature 1990, 346, 561-564.
183. Centonze, D.; Rossi, S.; Prosperetti, C.; Gasperi, V.; De Chiara, V.; Bari, M.; Tscherter, A.; Febbraro, F.; Bernardi, G.; Maccarrone, M. Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons. Mol. Cell. Neurosci. 2007, 35, 302-310.
184. Jung, K. M.; Mangieri, R.; Stapleton, C.; Kim, J.; Fegley, D.; Wallace, M.; Mackie, K.; Piomelli, D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 2005, 68, 1196-1202.
185. Katona, I.; Urban, G. M.; Wallace, M.; Ledent, C.; Jung, K. M.; Piomelli, D.; Mackie, K.; Freund, T. F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 2006, 26, 5628-5637.
186. Robbe, D.; Kopf, M.; Remaury, A.; Bockaert, J.; Manzoni, O. J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 2002, 99, 8384-8388.
187. Palazzo, E.; Marabese, I.; de Novellis, V.; Oliva, P.; Rossi, F.; Berrino, L.; Maione, S. Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology 2001, 40, 319-326.
188. De Vries, T. J.; Shaham, Y.; Homberg, J. R.; Crombag, H.; Schuurman, K.; Dieben, J.; Vanderschuren, L.; Schoffelmeer, A. N. M. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 2001, 7, 1151-1154.
189. Gubellini, P.; Saulle, E.; Centonze, D.; Costa, C.; Tropepi, D.; Bernardi, G.; Conquet, F.; Calabresi, P. Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology 2003, 44, 8-16.
190. Thandi, S.; Blank, J. L.; Challiss, R. A. J. Group-I metabotropic glutamate receptors, mG1u1a and mG1u5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J. Neurochem. 2002, 83, 1139-1153.
191. Kawabata, S.; Tsutsumi, R.; Kohara, A.; Yamaguchi, T.; Nakanishi, S.; Okada, M. Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors. Nature 1996, 383, 89-92.
192. Smith, F. L.; Smith, P. A.; Dewey, W. L.; Javed, R. R. Effects of mGlu(1) and mGlu(5) metabotropic glutamate antagonists to reverse morphine tolerance in mice. Eur. J. Pharmacol. 2004, 492, 137-142.
193. David, H. N.; Abraini, J. H. Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. Neuropharmacology 2003, 44, 717-727.
194. McGeehan, A. J.; Janak, P. H.; Olive, M. F. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Psychopharmacology 2004, 174, 266-273.
195. Kelley, A. E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004, 44, 161-179.
196. Lu, Y.-M.; Jia, Z.; Janus, C.; Henderson, J. T.; Gerlai, R.; Wojtowicz, J. M.; Roder, J. C. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 1997, 17, 5196-5205.
197. Jia, Z. P.; Lu, Y. M.; Agopyan, N.; Roder, J. Gene targeting reveals a role for the glutamate receptors mGluR5 and GluR2 in learning and memory. Physiol. Behav. 2001, 73, 793-802.
198. Balschun, D.; Wetzel, W. Inhibition of mGluR5 blocks hippocampal UP in vivo and spatial leaming in rats. Pharmacol. Biochem. Behav. 2002, 73, 375-380.
199. Manahan-Vaughan, D.; Braunewell, K. H. The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb. Cortex 2005, 15, 1703-1713.
200. Markou, A. The role of metabotropic glutamate receptors in drug reward, motivation and dependence. Drug News Perspect. 2007, 20, 103-108.
201. Baptista, M. A. S.; Martin-Fardon, R.; Weiss, F. Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: Comparison between cocaine and a potent conventional reinforcer. J. Neurosci. 2004, 24, 4723-4727.
202. Bossert, J. M.; Busch, R. F.; Gray, S. M. The novel mGluR(2/3) agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 2005, 16, 1013-1016.